Stock screenerAll disclosures →
EDGAR →
ADPT
Conviction 91HealthcareScan · Thu, Sep 24, 2026Adaptive Biotechnologies Corp (ADPT) closed at $29.57 (+6.02%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 73, RS Rating 97, at a 52-week high, +85.9% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).
ADPT$29.57+6.02%
ResistanceSupportVol 14Insider sell4
5
3
3
Vol MA14 2.37M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Adaptive Biotechnologies CorpBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.adaptivebiotech.com ↗
Price29.57
Change+6.02%
Gap-1.09%
Rel volume1.54×
Avg volume2.21M
Avg $ vol58.91M
SMA 2026.06
SMA 5024.84
SMA 20018.26
Price vs 50+19.05%
Price vs 200+61.92%
MA stackbullish
50/200 cross—
Supertrendup · 24.76
RSI (14)73
MACD hist0.31
MACD crossbull · 6d
Stoch %K / %D100 / 90
ADX (14)25
+DI / −DI27 / 14
RSI divergence—
MACD divergence—
ATR %4.23%
ADR %4.48%
52w high29.57
52w low12.41
From 52w high+0.00%
Above 52w low+138.28%
New 52w highYes
SqueezeOff
Bollinger width27.71%
%B0.99
Donchian pos100.00%
Donchian high29.57
Donchian low23.53
AVWAP (52w high)28.91
vs AVWAP high+2.29%
AVWAP (52w low)19.35
vs AVWAP low+52.79%
OBV trendUp
Chaikin MF (20)0.26
Today vs 20d1.54×
Avg vol (14d)2.37M
Avg vol (20d)2.21M
Avg $ vol (20d)58.91M
Market cap4.72B
RS Rating97 / 99
RS 3m (vs SPY)+41.53%
RS 6m (vs SPY)+92.16%
RS line new highYes
Trend template8/8
Technical rank97.3
1 week+3.57%
1 month+12.65%
3 months+46.02%
6 months+108.98%
1 year+112.28%
YTD+85.86%
P/E-79.32
P/B33.02
P/S17.04
P/FCF-96.42
EPS-0.3900
Div yield—
ROE-41.63%
ROA-9.29%
Debt/Eq0.00
Current4.79
EV/EBITDA-110.63
Gross margin—
Net margin-21.48%
Rev growth54.77%
EPS growth62.69%
Price target27.25
Target upside-7.85%
Analyst ratingBuy
Institutional104.98%
Ent. value4.55B
Revenue71.55M
Net income-39.79M
Gross profit—
Free cash flow-48.95M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out160.04M
Employees624
ListedThu, Jun 27, 2019
Free float113.41M
Float %74.3%
Short interest11.71M
Days to cover6.4d
Short volume26.5%
Squeeze score54 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.10 vs −$0.13
Last surprise+23.1% beat
Setup gradeA+
Conviction91 / 100
Pattern quality—
Tech rank97.3 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance28.75
Support22.68
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- BTIG maintains Buy rating on Adaptive Biotechnologies, $34 price targetTradingView · Tue, Sep 22, 2026
- Adaptive Biotechnologies (ADPT) Could Be 11% Overvalued Following The Guideline Updatesimplywall.st · Mon, Sep 21, 2026
- Adaptive Biotechnologies Stock: 5 Straight Green Days, Up 18%Trefis · Mon, Sep 21, 2026
Congress activity
Disclosed STOCK Act trades in ADPT
No recent disclosed trades by Congress in ADPT. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ADPT · open-market 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BOBULSKY SUSAN Chief Commercial Officer, MRD · Common Stock · 2026-09-15 | Sell | 1.2K | $32K | 2026-09-15 | 2026-09-17 |
OWEN KATEY EINTERZ Director · Common Stock · 2026-08-31 | Gift | 12.54K | — | 2026-08-31 | 2026-09-02 |
OWEN KATEY EINTERZ Director · Common Stock · 2026-08-26 | Sell | 9.62K | $250K | 2026-08-26 | 2026-08-28 |
HERSHBERG ROBERT Director · Stock Option (right to buy) · 2026-08-18 | Exercise | 15K | — | 2026-08-18 | 2026-08-20 |
HERSHBERG ROBERT Director · Common Stock · 2026-08-18 | Exercise | 15K | $95K | 2026-08-18 | 2026-08-20 |
HERSHBERG ROBERT Director · Common Stock · 2026-08-18 | Sell | 15K | $366K | 2026-08-18 | 2026-08-20 |
HERSHBERG ROBERT Director · Common Stock · 2026-08-18 | Sell | 15.66K | $382K | 2026-08-18 | 2026-08-20 |
ROBINS CHAD M CEO and Chairman · Stock Option (right to buy) · 2026-08-18 | Exercise | 278.68K | — | 2026-08-18 | 2026-08-19 |
ROBINS CHAD M CEO and Chairman · Common Stock · 2026-08-18 | Exercise | 278.68K | $1.8M | 2026-08-18 | 2026-08-19 |
ROBINS CHAD M CEO and Chairman · Common Stock · 2026-08-18 | Sell | 278.47K | $6.8M | 2026-08-18 | 2026-08-19 |
SEC filings
EDGAR filings in ADPT · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.